| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0947 |
| Trial ID | ChiCTR2100051028 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CDl9 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I Trial of Anti-CD19 Universal CAR-T Therapy For Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
| Year | 2021 |
| Country | China |
| Company sponsor | Tangdu Hospital, Fourth Military Medical University |
| Cohort 1 | |||||||
|
|||||||